Singapore markets open in 5 hours 5 minutes
Straits Times Index
3,264.53 -35.51 (-1.08%) S&P 500
5,188.87 +1.17 (+0.02%) Dow
39,068.54 +184.28 (+0.47%) Nasdaq
16,302.75 -29.81 (-0.18%) Bitcoin USD
62,296.34 -807.12 (-1.28%) CMC Crypto 200
1,320.53 +25.85 (+2.00%)
SciSparc Ltd. (SPRC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:43PM EDT. Market open.
| Previous close | 1.2200 |
| Open | 1.2400 |
| Bid | 1.2300 x 300 |
| Ask | 1.2600 x 400 |
| Day's range | 1.2300 - 1.2500 |
| 52-week range | 1.1500 - 23.6600 |
| Volume | |
| Avg. volume | 851,463 |
| Market cap | 3.326M |
| Beta (5Y monthly) | 1.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Benzinga
EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds
On Tuesday, Clearmind Medicine Inc (NASDAQ:CMND) submitted three additional patent applications under the international Patent Cooperation Treaty (PCT) as part of its ongoing collaboration with SciSparc Ltd (NASDAQ:SPRC). The patent applications refer to novel proprietary compositions of 3,4-methylenedioxymethamphetamine (MDMA), Ibogaine, and Ketamine, each with Palmitoylethanolamide (PEA), the active ingredient of SciSparc’s proprietary CannAmide. These were previously filed as provisional pate
© 2024 Yahoo. All rights reserved.